Ziprasidone

Sold as Geodon, Geodon im, Zipsid, Ziporid, Zidopriz, Zipdon

C₂₁H₂₁ClN₄OS412.90 g/mol

5-[2-[4-(1,2-Benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one

Drag to rotate. Structure from PubChem CID 60854.

Loading Wikipedia summary

Registration

Applicants: 4
Registrations: 18
Schedule source: Consolidated Schedules 06 July 2026

Applicants and registrations

Applicant	Brands	Dosages	Registrations	Schedule	Leaflets
Viatris Healthcare (Pty) Ltd	Geodon, Geodon im	20 mg, 20 mg/ml, 40 mg, 60 mg, 80 mg	320584, 320585, 320586, 320587, 360478	S5	None
Macleods Pharmaceuticals SA (Pty) Ltd	Zipsid	20 MG, 40 MG, 60 MG, 80 MG	480710, 480711, 480712, 480713	S5	None
Aurogen South Africa (Pty) Ltd	Ziporid, Zidopriz	20 mg, 40 mg, 60 mg, 80 mg	590266, 590267, 590268, 590269, 590270.266, 590271.267, 590272.268, 590273.269	S5	None
Pps Pharmaceuticals (Pty) Ltd	Zipdon	20 mg	590507	S5	PI PIL

Variants

Product	Strength and form	Registration	Status	Schedule	Leaflets
Geodon 20 MG EACH CAPSULE CONTAINS ZIPRASIDONE HYDROCHLORIDE EQUIVALENT TO ZIPRASIDONE 20,0 mg	20 mg	32058432/2.6.5/0584	Registered	S5	None
Geodon 40 MG EACH CAPSULE CONTAINS ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE EQUIVALENT TO ZIPRASIDONE 40,0 mg	40 mg	32058532/2.6.5/0585	Registered	S5	None
Geodon 60 MG EACH CAPSULE CONTAINS ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE EQUIVALENT TO ZIPRASIDONE 60,0 mg	60 mg	32058632/2.6.5/0586	Registered	S5	None
Geodon 80 MG EACH CAPSULE CONTAINS ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE EQUIVALENT TO ZIPRASIDONE 80,0 mg	80 mg	32058732/2.6.5/0587	Registered	S5	None
Geodon im 20 mg/ml EACH 1,0 ml SOLUTION CONTAINS ZIPRASIDONE 20,0 mg	20 mg/ml	36047836/2.6.5/0478	Registered	S5	None
Zipsid 20 MG Each capsule contains ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE 20,0 mg	20 MG	48071048/2.6.5/0710	Registered	S5	None
Zipsid 40 MG Each capsule contains ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE 40,0 mg	40 MG	48071148/2.6.5/0711	Registered	S5	None
Zipsid 60 MG Each capsule contains ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE 60,0 mg	60 MG	48071248/2.6.5/0712	Registered	S5	None
Zipsid 80 MG Each capsule contains ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE 80,0 mg	80 MG	48071348/2.6.5/0713	Registered	S5	None
Ziporid 20 MG EACH CAPSULE CONTAINS: ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE EQUIVALENT TO ZIPRASIDONE 20,0 mg	20 mg	59026659/2.6.5/0266	Registered	S5	None
Ziporid 40 MG EACH CAPSULE CONTAINS: ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE EQUIVALENT TO ZIPRASIDONE 40,0 mg	40 mg	59026759/2.6.5/0267	Registered	S5	None
Ziporid 60 MG EACH CAPSULE CONTAINS: ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE EQUIVALENT TO ZIPRASIDONE 60,0 mg	60 mg	59026859/2.6.5/0268	Registered	S5	None
Ziporid 80 MG EACH CAPSULE CONTAINS: ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE EQUIVALENT TO ZIPRASIDONE 80,0 mg	80 mg	59026959/2.6.5/0269	Registered	S5	None
Zidopriz 20 MG EACH CAPSULE CONTAINS: ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE EQUIVALENT TO ZIPRASIDONE 20,0 mg	20 mg	590270.26659/2.6.5/0270.266	Registered	S5	None
Zidopriz 40 MG EACH CAPSULE CONTAINS: ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE EQUIVALENT TO ZIPRASIDONE 40,0 mg	40 mg	590271.26759/2.6.5/0271.267	Registered	S5	None
Zidopriz 60 MG EACH CAPSULE CONTAINS: ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE EQUIVALENT TO ZIPRASIDONE 60,0 mg	60 mg	590272.26859/2.6.5/0272.268	Registered	S5	None
Zidopriz 80 MG EACH CAPSULE CONTAINS: ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE EQUIVALENT TO ZIPRASIDONE 80,0 mg	80 mg	590273.26959/2.6.5/0273.269	Registered	S5	None
Zipdon EACH VIAL CONTAINS: ZIPRASIDONE MESYLATE 20,0 mg	20 mgPowder for solution for injection	59050759/2.6.5/0507Approved 30 June 2026	Registered	S5	PI PIL

Regulatory status

Where S5 sits on the scale

S0S1S2S3S4S5S6S7S8

Prescription-only, with tighter controls on repeats.

Schedule 5 medicines need a prescription, and repeat dispensing is capped at six months in total; the prescriber must state upfront how many times, and at what intervals, it may be repeated. Extra limits apply to some uses: if it is being used for its anxiolytic, antidepressant, tranquillising or analgesic properties, it cannot be prescribed for longer than six months without a further consultation. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S5, matched to the Consolidated Schedules by ingredient, confidence high.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it.

Consolidated Schedules listings for Ziprasidone hydrochloride equivalent to ziprasidone

S5: Ziprasidone
Consolidated Schedules 06 July 2026, line 9773

Pharmacological class: Miscellaneous structures. (class 2.6.5)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

Schedule verified from official documents

Schedule Verification

Zipdon, Pps Pharmaceuticals (Pty) Ltd is scheduled S5 in its official SAHPRA documents, read with 90% confidence.

Professional information (PI)For healthcare professionalsZipdon, Pps Pharmaceuticals (Pty) Ltd Patient information leaflet (PIL)For patients and carersZipdon, Pps Pharmaceuticals (Pty) Ltd

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Research articles

Loading PubMed articles

Background